Carl Zeiss Meditec AG

AFX

Company Profile

  • Business description

    Carl Zeiss Meditec is one of the largest visioncare technology companies in the world, and it operates in two segments: ophthalmic devices and microsurgery. OPT, which made up 75% of sales in 2022, includes refractive lasers, surgical ophthalmic devices, equipment for ophthalmic diagnostics, as well as a portfolio of intraocular lenses and disposable medical instruments. With a low-teens share of the market, Zeiss is the second-largest player in the space. MCS is composed of implants, surgical instruments, and visualization devices used during neurosurgery, spine surgery, and otolaryngology surgery. With over 60% market share, Zeiss is the clear leader in the microsurgery space.

  • Contact

    Goschwitzer Strasse 51-52
    JenaTH07745
    DEU

    T: +49 3641220115

    https://www.zeiss.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Medical Instruments & Supplies

    Fiscal Year End

    30 September 2026

    Employees

    5,784

Stocks News & Analysis

stocks

2 ASX shares that benefit from sticky inflation

Inflation is a key risk to shareholders. Here’s why these two ASX shares benefit from higher inflation.
stocks

Our view of Dexus / Scentre deal

Dexus acquires stake in Westfiend Chermside.
stocks

Undervalued ASX retailer benefiting from rebound in spending

Uplift in sales momentum continues.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,923.807.50-0.08%
CAC 408,124.8856.260.70%
DAX 4024,229.9143.420.18%
Dow JONES (US)48,349.51108.54-0.22%
FTSE 1009,751.31102.281.06%
HKSE25,628.88347.91-1.34%
NASDAQ23,105.1290.05-0.39%
Nikkei 22550,168.11668.44-1.31%
NZX 50 Index13,408.141.230.01%
S&P 5006,816.4111.00-0.16%
S&P/ASX 2008,635.008.90-0.10%
SSE Composite Index3,867.9221.42-0.55%

Market Movers